RDP Life Sciences Limited 10733091 false 2023-05-01 2024-04-30 2024-04-30 The principal activity of the company is Life Science Research Digita Accounts Production Advanced 6.30.9574.0 true 10733091 2023-05-01 2024-04-30 10733091 2024-04-30 10733091 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 10733091 bus:Micro-entities 2023-05-01 2024-04-30 10733091 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 10733091 bus:FilletedAccounts 2023-05-01 2024-04-30 10733091 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 10733091 bus:RegisteredOffice 2023-05-01 2024-04-30 10733091 bus:Director2 2023-05-01 2024-04-30 10733091 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 10733091 countries:EnglandWales 2023-05-01 2024-04-30 10733091 2022-05-01 2023-04-30 10733091 2023-04-30 10733091 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 iso4217:GBP xbrli:pure

Registration number: 10733091

RDP Life Sciences Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 April 2024

 

RDP Life Sciences Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

1

 

RDP Life Sciences Limited

(Registration number: 10733091)
Balance Sheet as at 30 April 2024

2024
£

2023
£

Fixed assets

1,117

1,489

Current assets

109,614

112,563

Creditors: Amounts falling due within one year

(3,222)

(2,814)

Net current assets

106,392

109,749

 

107,509

111,238

Capital and reserves

107,509

111,238

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The company's registered number is 10733091.

The address of its registered office is:
13 Copse Way
Cambridge
CB2 8BJ

These financial statements were authorised for issue by the Board on 20 August 2024.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 0).

For the financial year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

 

RDP Life Sciences Limited

(Registration number: 10733091)
Balance Sheet as at 30 April 2024

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 20 August 2024 and signed on its behalf by:
 

.........................................
Dr Robert Denham Pinnock
Director